Despite the fact that biopharmaceuticals offer significant profit margins, innovator companies are plagued by high costs of development, complex production ...

A steadily growing demand for biologic fill / finish services has generated a range of new opportunities for contract service providers; stakeholders have ...

Recent advances in the manufacturing technologies have prompted pharmaceutical companies to consider shifting from the traditional multi-step, batch ...